» Articles » PMID: 17878369

Genetic Variation in PTPN22 Corresponds to Altered Function of T and B Lymphocytes

Overview
Journal J Immunol
Date 2007 Sep 20
PMID 17878369
Citations 161
Authors
Affiliations
Soon will be listed here.
Abstract

A variant of the PTPN22 gene, 1858C/T, is associated with an increased risk for the development of a wide array of autoimmune disorders. It is known that the protein tyrosine phosphatase Lyp encoded by this gene has an inhibitory effect on the proximal TCR signaling pathways. However, the consequences of carrying this variant and the mechanism by which it contributes to the development of autoimmunity are poorly understood. In this study, we demonstrate that homozygosity for this variant results in a profound deficit in T cell responsiveness to Ag stimulation. Heterozygosity for the variant allele is associated with reduced responsiveness of CD4+ memory T cells, characterized by diminished calcium mobilization, expression of CD25, and IL-10 production upon TCR stimulation. Additionally, the presence of the variant allele is associated with an increase in circulating memory T cells. We further demonstrate that these effects are not limited to the T cell compartment. Individuals with the variant allele have fewer memory B cells and these cells display a reduced response to stimulation via the BCR indicative of a B cell intrinsic defect. By identifying an immunologic phenotype in healthy subjects which correlates with the PTPN22 1858C/T genotype, we can now explore specific hypotheses regarding pathogenesis of diseases associated with the PTPN22 1858T variant.

Citing Articles

Deciphering autoimmune susceptibility: a meta-analysis of PTPN22 gene variants.

Thomas S, Veerabathiran R Immunol Res. 2025; 73(1):59.

PMID: 40067478 DOI: 10.1007/s12026-025-09614-9.


Protein phosphatases in systemic autoimmunity.

Pan W, Tsokos M, Li W, Tsokos G Immunometabolism (Cobham). 2025; 7(1):e00056.

PMID: 39944077 PMC: 11812671. DOI: 10.1097/IN9.0000000000000056.


Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy.

Jassim B, Bai Y, Qu Z, Sander C, Lin J, Miao J Eur J Med Chem. 2024; 283():117129.

PMID: 39693863 PMC: 11709133. DOI: 10.1016/j.ejmech.2024.117129.


Regulation of T Cell Signaling and Immune Responses by PTPN22.

Brownlie R, Salmond R Mol Cell Biol. 2024; 44(10):443-452.

PMID: 39039893 PMC: 11486154. DOI: 10.1080/10985549.2024.2378810.


Low-frequency and rare genetic variants associated with rheumatoid arthritis risk.

Kronzer V, Sparks J, Raychaudhuri S, Cerhan J Nat Rev Rheumatol. 2024; 20(5):290-300.

PMID: 38538758 DOI: 10.1038/s41584-024-01096-7.